Moreover, our preliminary data from childhood cancer neuroblastoma revealed that IER3 is a p53 dependent tumor suppressor and its higher expression predicts better prognosis in multiple neuroblastoma patient cohorts. This evidence concerns the gene IER3 and neuroblastoma.